InMed Pharmaceuticals Inc (NASDAQ:INM) has a beta value of 0.74 and has seen 0.89 million shares traded in the last trading session. The company, currently valued at $0.73M, closed the last trade at $0.22 per share which meant it gained $0.01 on the day or 5.80% during that session. The INM stock price is -845.45% off its 52-week high price of $2.08 and 45.45% above the 52-week low of $0.12. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.24 million shares traded. The 3-month trading volume is 6.80 million shares.
The consensus among analysts is that InMed Pharmaceuticals Inc (INM) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
InMed Pharmaceuticals Inc (NASDAQ:INM) trade information
Sporting 5.80% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the INM stock price touched $0.22 or saw a rise of 2.91%. Year-to-date, InMed Pharmaceuticals Inc shares have moved -47.36%, while the 5-day performance has seen it change 5.04%. Over the past 30 days, the shares of InMed Pharmaceuticals Inc (NASDAQ:INM) have changed -12.96%. Short interest in the company has seen 93164.0 shares shorted with days to cover at 0.09.
InMed Pharmaceuticals Inc (INM) estimates and forecasts
The company’s shares have lost -28.30% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 53.87% over the past 5 years.
INM Dividends
InMed Pharmaceuticals Inc is expected to release its next earnings report in November this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
InMed Pharmaceuticals Inc (NASDAQ:INM)’s Major holders
Insiders own 0.62% of the company shares, while shares held by institutions stand at 5.55% with a share float percentage of 5.58%. Investors are also buoyed by the number of investors in a company, with InMed Pharmaceuticals Inc having a total of 14.0 institutions that hold shares in the company. The top two institutional holders are SABBY MANAGEMENT, LLC with over 0.31 million shares worth more than $81571.0. As of 2024-06-30, SABBY MANAGEMENT, LLC held 3.1961% of shares outstanding.
The other major institutional holder is VIRTU FINANCIAL LLC, with the holding of over 86684.0 shares as of 2024-06-30. The firm’s total holdings are worth over $23000.0 and represent 0.9017% of shares outstanding.
